Your browser doesn't support javascript.
Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study.
Schurink, Bernadette; Roos, Eva; Radonic, Teodora; Barbe, Ellis; Bouman, Catherine S C; de Boer, Hans H; de Bree, Godelieve J; Bulle, Esther B; Aronica, Eleonora M; Florquin, Sandrine; Fronczek, Judith; Heunks, Leo M A; de Jong, Menno D; Guo, Lihui; du Long, Romy; Lutter, Rene; Molenaar, Pam C G; Neefjes-Borst, E Andra; Niessen, Hans W M; van Noesel, Carel J M; Roelofs, Joris J T H; Snijder, Eric J; Soer, Eline C; Verheij, Joanne; Vlaar, Alexander P J; Vos, Wim; van der Wel, Nicole N; van der Wal, Allard C; van der Valk, Paul; Bugiani, Marianna.
  • Schurink B; Department of Pathology, Amsterdam University Medical Centers (UMC), VU University Amsterdam, Amsterdam, Netherlands.
  • Roos E; Department of Pathology, Amsterdam University Medical Centers (UMC), VU University Amsterdam, Amsterdam, Netherlands.
  • Radonic T; Department of Pathology, Amsterdam University Medical Centers (UMC), VU University Amsterdam, Amsterdam, Netherlands.
  • Barbe E; Department of Pathology, Amsterdam University Medical Centers (UMC), VU University Amsterdam, Amsterdam, Netherlands.
  • Bouman CSC; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
  • de Boer HH; Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
  • de Bree GJ; Department of Forensic Medicine, Netherlands Forensic Institute, The Hague, Netherlands.
  • Bulle EB; Department of Internal Medicine, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
  • Aronica EM; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
  • Florquin S; Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
  • Fronczek J; Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
  • Heunks LMA; Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
  • de Jong MD; Department of Forensic Medicine, Netherlands Forensic Institute, The Hague, Netherlands.
  • Guo L; Department of Intensive Care Medicine, Amsterdam University Medical Centers (UMC), VU University Amsterdam, Amsterdam, Netherlands.
  • du Long R; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
  • Lutter R; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
  • Molenaar PCG; Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
  • Neefjes-Borst EA; Department of Pulmonary Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
  • Niessen HWM; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
  • van Noesel CJM; Department of Pulmonary Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
  • Roelofs JJTH; Department of Pathology, Amsterdam University Medical Centers (UMC), VU University Amsterdam, Amsterdam, Netherlands.
  • Snijder EJ; Department of Pathology, Amsterdam University Medical Centers (UMC), VU University Amsterdam, Amsterdam, Netherlands.
  • Soer EC; Department of Cardiac Surgery, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers (UMC), VU University Amsterdam, Amsterdam, Netherlands.
  • Verheij J; Department of Pathology, Amsterdam University Medical Centers (UMC), VU University Amsterdam, Amsterdam, Netherlands.
  • Vlaar APJ; Department of Pathology, Amsterdam University Medical Centers (UMC), VU University Amsterdam, Amsterdam, Netherlands.
  • Vos W; Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, Netherlands.
  • van der Wel NN; Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
  • van der Wal AC; Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
  • van der Valk P; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
  • Bugiani M; Department of Pathology, Amsterdam University Medical Centers (UMC), VU University Amsterdam, Amsterdam, Netherlands.
Lancet Microbe ; 1(7): e290-e299, 2020 11.
Article in English | MEDLINE | ID: covidwho-1087376
ABSTRACT

BACKGROUND:

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) targets multiple organs and causes severe coagulopathy. Histopathological organ changes might not only be attributable to a direct virus-induced effect, but also the immune response. The aims of this study were to assess the duration of viral presence, identify the extent of inflammatory response, and investigate the underlying cause of coagulopathy.

METHODS:

This prospective autopsy cohort study was done at Amsterdam University Medical Centers (UMC), the Netherlands. With informed consent from relatives, full body autopsy was done on 21 patients with COVID-19 for whom autopsy was requested between March 9 and May 18, 2020. In addition to histopathological evaluation of organ damage, the presence of SARS-CoV-2 nucleocapsid protein and the composition of the immune infiltrate and thrombi were assessed, and all were linked to disease course.

FINDINGS:

Our cohort (n=21) included 16 (76%) men, and median age was 68 years (range 41-78). Median disease course (time from onset of symptoms to death) was 22 days (range 5-44 days). In 11 patients tested for SARS-CoV-2 tropism, SARS-CoV-2 infected cells were present in multiple organs, most abundantly in the lungs, but presence in the lungs became sporadic with increased disease course. Other SARS-CoV-2-positive organs included the upper respiratory tract, heart, kidneys, and gastrointestinal tract. In histological analyses of organs (sampled from nine to 21 patients per organ), an extensive inflammatory response was present in the lungs, heart, liver, kidneys, and brain. In the brain, extensive inflammation was seen in the olfactory bulbs and medulla oblongata. Thrombi and neutrophilic plugs were present in the lungs, heart, kidneys, liver, spleen, and brain and were most frequently observed late in the disease course (15 patients with thrombi, median disease course 22 days [5-44]; ten patients with neutrophilic plugs, 21 days [5-44]). Neutrophilic plugs were observed in two forms solely composed of neutrophils with neutrophil extracellular traps (NETs), or as aggregates of NETs and platelets..

INTERPRETATION:

In patients with lethal COVID-19, an extensive systemic inflammatory response was present, with a continued presence of neutrophils and NETs. However, SARS-CoV-2-infected cells were only sporadically present at late stages of COVID-19. This suggests a maladaptive immune response and substantiates the evidence for immunomodulation as a target in the treatment of severe COVID-19.

FUNDING:

Amsterdam UMC Corona Research Fund.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombosis / Blood Coagulation Disorders / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Lancet Microbe Year: 2020 Document Type: Article Affiliation country: S2666-5247(20)30144-0

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombosis / Blood Coagulation Disorders / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Lancet Microbe Year: 2020 Document Type: Article Affiliation country: S2666-5247(20)30144-0